- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Applicare extends contract with Picker
Applicare extends contract with PickerContrary to speculation that GE Medical Systems’ acquisition of Applicare Medical Imaging would impact the Dutch PACS firm’s OEM distribution relationships (PNN 6/99), Applicare has extended
Applicare extends contract with Picker
Contrary to speculation that GE Medical Systems acquisition of Applicare Medical Imaging would impact the Dutch PACS firms OEM distribution relationships (
PNN
6/99), Applicare has extended its PACS software supply contract with key partner Picker International through 2004. Cleveland-based Picker has been integrating Applicares RadWorks software into its PACS since 1997 and plans to continue beta testing RadWorks 5.0 with such institutions as the University of Utah and the University of Wisconsin. Picker claims an installed base of nearly 500 Radworks licenses in the U.S. and other countries.
The contract extension is further proof that we take our multichannel strategy seriously and that well support Picker with product development for years to come, said Ruud Kroon, Applicare CEO.
- Search again
- Homepage
New AI-Powered Ultrasound Devices May Enhance Efficiency in Women's Imaging
April 19th 2024One of the features on the new Voluson Signature 20 and 18 ultrasound devices reportedly uses automated AI tools to facilitate a 40 percent reduction in the time it takes to perform second trimester exams.
FDA Approves Fluorescence Imaging System for Detecting Residual Breast Cancer
April 18th 2024The combination of the optical imaging agent Lumisight and the fluorescence imaging device Lumicell Direct Visualization System, collectively known as LumiSystem, reportedly offers 84 percent accuracy with real-time detection of residual breast cancer after lumpectomy procedures.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
